Koers Marapharm Ventures Inc Deutsche Boerse AG
Aandelen
CA56575M1086
Gezondheidszorgvoorzieningen & -diensten
Omzet 2020 | 2,27 2,09 | Omzet 2021 | 3,15 2,91 | Marktkapitalisatie | 10,06 mln. 9,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -40 mln. -36,94 mln. | Nettowinst (verlies) 2021 | -8 mln. -7,39 mln. | EV/omzet 2020 | 13.592.488 x |
Nettoschuld 2020 | 5,3 mln. 4,9 mln. | Nettoschuld 2021 | 13,31 mln. 12,29 mln. | EV/omzet 2021 | 7.417.546 x |
K/w-verhouding 2020 |
-0,45
x | K/w-verhouding 2021 |
-1,08
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 71,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Searle
IRO | Public Communications Contact | - | - |
James O’Sullivan
SEC | Corporate Secretary | - | 18-11-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott R. Berman
BRD | Director/Board Member | - | - |
Dylan Rexing
BRD | Director/Board Member | - | 08-10-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,58% | 212 mln. | |
-19,59% | 175 mln. | |
+25,58% | 165 mln. | |
-28,57% | 121 mln. | |
+300,00% | 121 mln. | |
+85,62% | 110 mln. | |
+26,09% | 110 mln. | |
-56,87% | 84,3 mln. | |
+15,38% | 73,86 mln. |